These results indicate that [Bi-213]anti-CD20 reversed deficient activation of caspases and apoptotic pathways via downregulation of XIAP and Bcl-xL specifically in CD20-positive NHL cells. This evidence concerns the gene XIAP and non-Hodgkin lymphoma.